Expand LRMR Menu
LRMR MENU

LRMR Latest Press Releases

-- August 4, 2026 --

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update Globe Newswire 7:00 AM

-- July 23, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 10:01 AM

-- July 21, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Larimar Therapeutics, Inc. - LRMR Globe Newswire 1:01 PM

-- July 9, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 7:58 PM

-- July 7, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR Globe Newswire 6:04 PM

-- July 1, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 8:11 PM

-- June 29, 2026 --

Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich's Ataxia Globe Newswire 6:30 AM

-- June 26, 2026 --

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich's Ataxia Globe Newswire 4:05 PM

-- May 14, 2026 --

Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update Globe Newswire 7:00 AM

-- April 30, 2026 --

Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich's Ataxia Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes